Scientists trace Painkiller's path to unborn babies
NCT ID NCT02962830
Summary
This study aimed to understand how a strong pain medication moves between a pregnant person and their fetus. It involved eight people undergoing pregnancy termination due to severe fetal malformations after 24 weeks. Researchers injected the medication into the amniotic fluid and measured its levels in the mother, fetus, and fluid to gather basic safety data.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRENATAL DIAGNOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Jeanne de Flandres, CHRU
Lille, France
Conditions
Explore the condition pages connected to this study.